Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07324239

TECAR Therapy on Pain and Quality of Life in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Effect of TECAR Therapy on Pain and Quality of Life in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: a Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Middle East University · Academic / Other
Sex
Male
Age
30 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Evaluate the effect of TECAR therapy on pain, voiding, erectile function, sleep quality and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome.

Detailed description

Sixty men with chronic prostatitis/chronic pelvic pain will be sourced from the urology outpatient clinic at Tanta University hospitals in Egypt, with referrals from urologists. Patients will be randomly assigned into two groups. Study group: It will include 30 men receiving true TECAR therapy plus dietary and life style adjustments. Control group: It will include 30 men receiving sham TECAR therapy plus dietary and life style adjustments. Evaluation Procedures: 1. Pain, voiding, and quality of life using the National Institutes of Health-Chronic Prostatitis Symptom Index. 2. Sleep quality using the Pittsburgh Sleep Quality Index. 3. Erectile function using the International Index of Erectile Function.

Conditions

Interventions

TypeNameDescription
DEVICETECAR therapyWINBACK 3SE (France) will be used for TECAR therapy in this study. To facilitate optimal distribution of endogenous heat therapy and effective contact between the active electrodes, both capacitive and resistive, and the surface of the skin, a layer of high-conductivity cream will be applied to the treatment region. The plate, an inactive electrode, which has a specific size (21cm\*15cm), will be placed on the gluteal region. The capacitive electrode was employed for a duration of seven and a half minutes, at an intensity of 30-40%, whereas the resistance electrode will be utilized for an equivalent period over the perineum at the same intensity.
DEVICESham TECAR therapyThe procedure is similar to the active treatment of TECAR, but with the critical difference being that the output intensity of the TECAR device will be set to zero during the session.

Timeline

Start date
2026-01-02
Primary completion
2026-04-01
Completion
2026-04-07
First posted
2026-01-07
Last updated
2026-01-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07324239. Inclusion in this directory is not an endorsement.